Table 9 List of the repositioning candidates, therapeutic category and the supporting published evidence in \(\#Cluster_2\)
From: Using informative features in machine learning based method for COVID-19 drug repurposing
Candidate drug | Therapeutic category | References |
|---|---|---|
Mycophenolate mofetil | Anti-bacterial and anti-infective | [39] |
Erythromycin | Anti-bacterial and anti-infective | [40] |
Azithromycin | Anti-bacterial and anti-infective | [26] |
Cerivastatin | Anticholesteremic agents | [41] |
Ezetimibe | Anticholesteremic agents | [42] |
Fusidic acid | Anti-bacterial and anti-infective | – |
Canagliflozin | Alimentary tract and metabolism | [43] |
Letermovir | Antiviral agents | [44] |